Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03962712 · ClinicalTrials.gov registry record
A Natural Experiment Evaluating the Effect of a Minimum Wage Increase on Obesity and Diet-related Outcomes
A clinical trial of Obesity and Nutrition Poor, sponsored by University of Connecticut.
- Completed
- Registry status
- 974
- Enrollment target
- 1
- Study location
NCT03962712: Completed study of Obesity and Nutrition Poor, sponsored by University of Connecticut.
NCT03962712 is a study of Obesity and Nutrition Poor that has completed, run by University of Connecticut. The registered enrollment target is 974 participants, above the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03962712, a study of Obesity and Nutrition Poor, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- 974 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the effect of the Minneapolis minimum wage ordinance on change in body mass index among low-wage workers.
Primary Outcome
Body mass index (BMI) will be measured over 5 years among low-wage workers in Minneapolis compared to workers in a comparison (control) city, as assessed by objective annual height and weight measurements.
Conditions Studied
Interventions
- OTHER Increase Minimum Wage to $15-an-hour
- OTHER No Increase in Minimum Wage
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 974 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2023-03-20 |
What the finished NCT03962712 record still lists
NCT03962712 is an observational study that tracks outcomes without assigning an intervention. The registered 974 participants enrollment target is mid-sized for trials with a published cap, above the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (19% higher).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Increase Minimum Wage to $15-an-hour is the first listed.
NCT03962712 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03962712 about?
NCT03962712 is a clinical study titled "A Natural Experiment Evaluating the Effect of a Minimum Wage Increase on Obesity and Diet-related Outcomes". To evaluate the effect of the Minneapolis minimum wage ordinance on change in body mass index among low-wage workers.
What is the current status of trial NCT03962712?
This trial is currently completed. The enrollment target is 974 participants. The study started on 2018-02-01. Estimated completion is 2023-03-20.
What conditions does trial NCT03962712 study?
This clinical trial studies the following conditions: Obesity, Nutrition Poor.
What interventions are being tested in trial NCT03962712?
The interventions under investigation include: Increase Minimum Wage to $15-an-hour (OTHER), No Increase in Minimum Wage (OTHER).
Who is sponsoring clinical trial NCT03962712?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03962712 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03962712's enrollment target sits among peer trials
974 77th of 1053 higher than 977 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06948422 · 974 participants · Phase 3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- NCT05600777 · 975 participants · Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
- NCT06541704 · 975 participants · Phase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- NCT06820736 · 975 participants · NA
A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI